ライフサイエンスコーパス: radioprotection

1 ts that melanin also plays a pivotal role in radioprotection.

2 ective and selective strategy for intestinal radioprotection.

3 ith PD treatment for even greater intestinal radioprotection.

4 interleukin-7 prior to irradiation conferred radioprotection.

5 eukin-1 receptor signaling, are critical for radioprotection.

6 chanism of growth factor-mediated intestinal radioprotection.

7 appear to contribute to subsequent cutaneous radioprotection.

8 elets, or both are the critical effectors of radioprotection.

9 iodide uptake in the thyroid may be used in radioprotection.

10 essing STAT1alpha and STAT1beta demonstrated radioprotection after exposure to 3 Gy (P < 0.038).

11 ods for reagent purification, drug labeling, radioprotection and chromatographic purification.

12 after lethal total body irradiation provides radioprotection and gives rise to long-term hematopoieti

13 blood cell lineages: one that generates both radioprotection and long-term engraftment and one that p

14 ted that mouse LHSC are responsible for both radioprotection and long-term repopulation of all blood

15 ic Energy Agency and the French Institute of Radioprotection and Nuclear Safety.

16 However, HO-1(+/-) HSCs were ineffective in radioprotection and serial repopulation of myeloablated

17 However, these cells lacked radioprotection and spleen colony-forming activity.

18 Cs migrated to BM, self-replicated, provided radioprotection, and established long-term hematopoietic

19 Mouse models of SCF-mediated anaphylaxis, radioprotection, and hematopoietic expansion revealed th

20 in homing: PTX-treated cells did not provide radioprotection, and their short-term engraftment in BM

21 nstrate a nonredundant function of GM-CSF in radioprotection by donor hematopoietic cells that may pr

22 In addition, local muscle tissue radioprotection by lead shielding during irradiation pre

23 Cs results in diminished pool size, impaired radioprotection, defective repopulation, and loss of qui

24 quired and specific for erythroid short-term radioprotection following bone marrow transplantation.

25 promotes HSC regeneration and hematopoietic radioprotection following total body irradiation.

26 genetic radionuclide therapy, and free-flap radioprotection, have the potential to extend the role o

27 DMA showed an excellent radioprotection in mice at single nontoxic oral dose by

28 - c-kit+ Sca-1- cells (CD31+ Sca-1-) provide radioprotection in the absence of long-term donor-derive

29 ly, Toll-like receptor 5 stimulation confers radioprotection in the intestine.

30 entify IKKbeta as a key molecular target for radioprotection in the intestine.

31 A possible role for TLK1B in radioprotection is discussed.

32 e mechanism of Amifostine (WR-2721) mediated radioprotection is poorly understood.

33 monstrated accelerated BM cellular recovery, radioprotection of BM c-kit(+)sca-1(-)lin(-) progenitors

34 erived bone marrow cells provides short-term radioprotection of lethally irradiated recipients, whose

35 been postulated that the basis for selective radioprotection of normal tissues is greater bioreductio

36 e of thrombospondin-1 or CD47 provides local radioprotection of soft tissues and bone marrow.

37 ential molecular targets for pharmacological radioprotection of stem cells and hopefully improving th

38 These mice showed radioprotection of the HSC pool and 100% survival after

39 role of the RNA binding protein apobec-1 in radioprotection of the intestine.

40 g in the inhibition of CUGBP2 expression and radioprotection of the intestine.

41 hematopoietic cells and is critical for the radioprotection of these key cells.

42 though RIBEs have important implications for radioprotection, radiation safety and radiotherapy, the

43 ate delayed multilineage engraftment, while "radioprotection" (rapid engraftment that will prevent ea

44 Flagellin-elicited radioprotection required TLR5, the TLR signaling adaptor

45 pulating stem cells from cells that provided radioprotection (short-term repopulating cells) on the b

46 amaging cancer therapies, and development of radioprotection strategies.

47 sense-mediated suppression of CUGBP2 renders radioprotection through a COX-2-dependent prostaglandin

48 am68-dependent NF-kappaB activation provides radioprotection to colon epithelium in vivo.

49 eserved an immature cell phenotype, provided radioprotection to lethally irradiated recipients, and e

50 CD47 blockade has been found to confer radioprotection to normal tissues while enhancing tumor

51 This radioprotection was at least partially specific for norm

52 Flagellin-elicited radioprotection was, in part, mediated via effects on ce

53 The effects of PHD inhibition on GI radioprotection will be described in detail.

54 nistration of rIL-11 resulted in significant radioprotection with 89% of the rIL-11-treated animals s